Author

Pascale Van Belle

Institution: GlaxoSmithKline (Belgium)

Observed institution: GlaxoSmithKline (Belgium)

OpenAlex ID: A5081789263

Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers

2008 · Pierre Vandepapelière, Yves Horsmans, et al. · Vaccine · 216

Impact of adjuvants on CD4+ T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial

2016 · Geert Leroux-Roels, Arnaud Marchant, et al. · Clinical Immunology · 112

Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example

2009 · Jiří Beran, Veronika Wertzova, et al. · BMC Infectious Diseases · 80

Safety and immunogenicity of an investigational 4-component Staphylococcus aureus vaccine with or without AS03 B adjuvant: Results of a randomized phase I trial

2015 · Jack Levy, Laurent Licini, et al. · Human Vaccines & Immunotherapeutics · 65

Efficacy of Inactivated Split‐Virus Influenza Vaccine against Culture‐Confirmed Influenza in Healthy Adults: A Prospective, Randomized, Placebo‐Controlled Trial

2009 · Jiri Beran, Timo Vesikari, et al. · The Journal of Infectious Diseases · 63

Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: Randomised, controlled trials

2013 · Isabel Leroux-Roels, Jeanne-Marie Devaster, et al. · Vaccine · 62

Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination

2014 · Geert Leroux-Roels, Pascale Van Belle, et al. · Vaccine · 49

Randomized Controlled Study of the Safety and Immunogenicity of Pneumococcal Vaccine Formulations Containing PhtD and Detoxified Pneumolysin with Alum or Adjuvant System AS02 V in Elderly Adults

2014 · Karlis Pauksens, Anna C. Nilsson, et al. · Clinical and Vaccine Immunology · 42

AS01-adjuvanted vaccine induces a transient innate immune response in ă humans

2016 · Christine Hervé, Michelle A. E. Brouwer, et al. · HAL

Works count: 9

Citation count: 689

H-index: 8

I10-index: 8